Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Centre Jean Perrin
University of Southern California
TuHURA Biosciences, Inc.
Center for Biomedical Research, Inc.
Northwestern University
Rhode Island Hospital
Johns Hopkins University
Mayo Clinic
Washington University School of Medicine
Mayo Clinic
Stanford University
University of Pittsburgh
Washington University School of Medicine
University of Virginia
Mayo Clinic
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Siemens Molecular Imaging